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Sida acuta is shrub belonging to Malvaceae family. The plant is widely distributed in the subtropical 
regions where it is found in bushes, in farms and around habitations. Surveys conducted in indigenous 
places revealed that the plant had many traditional usages that varied from one region to another. The 
most cited illnesses are fever, headache and infections diseases. Indeed, many laboratory screening 
have been conducted to show the scientific rationale behind these usages and many compounds have 
been isolated from the plant. In the present review we listed the plant usages in folk medicine in some 
regions where the plant grows and we discussed on the confirmed in vitro activities after laboratory 
screenings. The review ended with the pharmacological properties of several compounds isolated from 
S. acuta principally alkaloids.  
 





Sida acuta is a malvaceous weed that frequently 
dominates improved pastures, waste and disturbed 
places roadsides (Mann et al., 2003). The plant is native 
to Mexico and Central America but has spread through-
out the tropics and subtropics (Holm et al., 1977). In 
traditional medicine, the plant is often assumed to treat 
diseases such as fever, headache, skin diseases, 
diarrhea, and dysentery. Referring to the traditional 
knowledge, studies have been carried out to confirm the 
activities the plant is assumed to exert in vivo. The 
described pharmacological properties of the plants in-
volve the antiplasmodial, antimicrobial, antioxidant, 
cytotoxic activities and many other properties. Some 
studies resulted in the isolation of single compounds 
while the others just demonstrated the activity of the 
crude extracts. The present review is focused on the 
traditional usages of the plant, the in vitro laboratory 
screening results and the pharmacological properties of 
some compounds isolated from the plant.  
 
 




S. acuta is widely distributed in pantropical areas and is 
widely used as traditional medicine in many cases. The 
plant is also used for spiritual practices. Table 1 displays 
the traditional usages of the plant in some regions where 
it grows. Among illnesses the plant is used to cure, fever 
is the most cited. The administration may be by oral route 
for example in the case of fever or by external application 
of the paste directly on the skin for skin diseases or 
snake bites (Kerharo and Adam, 1974). The plant may be 
used alone or in combination with other plants according 
to the diseases or to the healers. 
 
 
IN VITRO ACTIVITIES AND ISOLATED COMPOUNDS 
OF SIDA ACUTA 
 
Isolated compounds of the plant 
 
Several phytochemical screenings resulted in the isola-
tion of various compounds from the plant involving 
alkaloids and steroidal  compounds  (Cao  and  Qi,  1993;  
 




Table 1. Traditional usages of Sida acuta in several regions. 
 





Asthma, renal inflammation, colds, 
fever, headache, ulcers and worms 
(Caceres et al., 1987 ; 
Coee and Anderson, 1996) 
India (Ghats)  Pilla valatti 
chedi 
WP Fever, bronchitis, ulcer, diarrhea, 
dysentery, skin diseases. 
The paste of leaves is mixed with 
coconut oil and applied on head 
regularly for killing dandruffs and also 
for strengthening hair 
(Ignacimuthu et al., 2006; 
Malairajan et al., 2006) 
Kenya (Digo)  Mbundugo WP The plant is used to prepare 
"Bundugo", a supplementary strength 
magically added to a person 
(Pakia, 2005) 
Nigeria Iseketu WP, L malaria, ulcer, fever, gonorrhea, 
abortion, breast cancer, poisoning, 
inflammation, feed for livestock, stops 
bleeding, treatment of sores wounds 
antipyretic 
(Kayode, 2006; Edeoga et 
al., 2005 Saganuwan and 
Gulumbe, 2006) 
Togo  - L  Eczema, kidney stone, headache (Anani et al., 2000) 
Western Colombia - WP Snakebites (Otero et al., 2000) 
Sri Lanka - R, L Hemorrhoids, fevers, impotency, 
gonorrhea, and rheumatism. In 
mixture as aphrodisiac and for boils 
and eye cataracts 
(Dash, 1991; Pal and Jain, 
1998) 
Burkina Faso (Mossi 
Central Plate)  
Zon-Raaga WP Fever, diarrhea, pulmonary affection, 
snakebites, insects' bites. Paste of 
leaves mixed with salt is applied on 








Dinan et al., 2001). Figure 1 lists the chemical structure 
of some. The alkaloids occurring in the plant belong to 
the indoloquinolines family. The main alkaloids are 
cryptolepine and its derivatives such as quindoline, 
quindolinone, cryptolepinone and 11-methoxy-quindoline 
(Jang et al., 2003). The major steroids of the plant are 
ecdysterone, beta-sistosterol, stigmaterol, ampesterol. 
Phenolic compounds such as evofolin-A, and B, scopo-
letin vomifoliol, loliolid and 4-ketopinoresinol have also 





The in vitro antiplasmodial activity of the plant was first 
reported by Karou et al. (2003). The test was performed 
on fresh clinical isolates of Plasmodium falciparum using 
the in vitro semi microtest by light microscopy as 
described by Le Bras and Deloron (1983). Ethanolic 
extract of the plant was tested both with ethanolic extract 
of four other plants. As S. acuta was the most active plant 
of the study (IC50 value of 4.37 µg/mL), its extract was 
brought under liquid-liquid separation between petroleum 
ether, chloroform and water resulting in three fractions. 
These fractions tested on the parasites revealed that the 
chloroformic fraction and the aqueous fraction had similar 
activities while the ether fraction was devoid of intrinsic 
antiplasmodial activity. This suggested that alkaloids of 
the plant may be responsible for the activity. The issue of 
the study confirmed that the activity of the plant was 
related to its alkaloids which displayed IC50 value of 0.05 
µL/mg. Banzouzi et al. (2004) continued the work in the 
same way using one reference strain of P. falciparum: 
FcM29-Cameroon (chloroquine-resistant strain) and a 
Nigerian chloroquine-sensitive strain. The antiplasmodial 
assay was performed with ethanolic and aqueous extract 
by flow cytometry with incorporation of [3H] hypoxanthine 
(Desjardins et al., 1979; Schulze et al., 1997). The 
ethanolic extract showed good activity on the two strains 
with IC50 values between 3.9 and 5.4 µg/mL. The 
purification of this active extract led to the identification of 
cryptolepine as the antimalarial agent of the plant.  
It is evidence that the plant showed a good in vitro 
antimalarial activity related to its alkaloid contents. 
Referring to the traditional practices where the drug is 
often prepared by boiling plant material in water, this 
activity may be reduce in vivo since alkaloid solubility in 








The antimicrobial screening of S. acuta revealed that 
many compounds might be responsible for the activity of 
the plant. The first antimicrobial screening of the plant 
was conducted by Anani et al. (2000) using the disk 
diffusion assay. The authors found that the methanolic 
extract of the plant had a significant activity on Staphy-
lococcus aureus, Escherichia coli, Bacillus subtilis and 
Mycobacterium phlei, however the extract was not active 
on Streptococcus faecalis, Klebsiella pneumoniae, 
Salmonella thyphimurium, Pseudomonas aeruginosa and 
Candida albicans. The same findings were confirmed in 
another study using methanolic extract and similar 
microorganisms (Rajakaruna et al., 2002). Polyphenols 
and alkaloids of the plant were tested separately on 
several pathogenic bacteria including clinical strains and 
reference strains of Enterobacteriaceae and Staphyloco-
ccaceae families. The tests were performed by agar well 
diffusion (Perez et al., 1990) and the NCCLS (2000) broth 
microdilution assays. The results revealed that the 
phenolic compounds had a good in vitro antimicrobial 
activity and this activity was much influenced by the 
storage of the extract probably because of the phenolic 
compounds oxidization. The inhibition zone diameters 
varied from 11 to 25 mm for 250 µg polyphenols and 
MBC values ranged from 20 to 2000 µg/mL (Karou et al., 
2005). Alkaloids of Sida acuta also displayed a good 
antibacterial activity. The recorded inhibition zone 
diameters varied from 16 to 38 mm for 100 µg alkaloids 
and the MBC values from 80 to 400 µg/mL (Karou et al., 
2006). In another study, leaf/flower combination was 
evaluated for antimicrobial activity using hexane, chloro-
form, methanol and aqueous extraction methods. The 
antibacterial activities were exhibited by the four extract 
on E. coli, S. pyogenes, Pasterella multocida and S. 
typhimurium as there was no activity exhibited on S. 
typhi, S. pneumoniae and K. pneumoniae (Sanganuwan 
and Gulumbe, 2006). 
As many other plants with antibacterial properties, S. 
acuta contains phenolic compounds that are responsible 
for the activity of the plant. The current problem with 
phenolic compounds is the fact that they are vulnerable 
to polymerization in air through oxidation reactions. This 
oxidization may first affect the extractability of the 
phenolic compounds that is crucial in drug preparation; in 
this topic some authors suggested extracting the 
compounds directly on fresh material in order to enhance 
the yield (Scalbert, 1992). However, in our enquiries 
many traditional healers always dry their plant materials 
before the use, particularly when the plant does not grow 
around habitations (Karou et al., 2007). Secondly, an 
important factor governing the activity of phenolic 
compounds is their polymerization size. Oxidized conden-
sation of phenols may result in the toxification of 
microorganisms, while the adverse effects can be obser-
ved in  some cases (Scalbert,  1991;  Field  and  Lettinga,  




1992). Recently in the case of S. acuta we observed that 
the tested microorganisms were particularly susceptible 
to the stored extract (Karou et al., 2006). Therefore, it is 
now the time to think about how to prepare phenolics-
based drugs with traditional healers.  
 
 
Other in vitro activities 
 
Since S. acuta has several usages in folk medicine it has 
been involved in many other pharmacological screenings. 
The plant has been screened for its cancer chemo-
preventive properties by Jang et al. (2003). The study 
resulted in the isolation of several compounds, among 
them quindolinone, cryptolepinone and 11-
methoxyquindoline was found to induce quinone 
reductase activity, while cryptolepinone, N-
transferuloyltyramine exhibited a significant inhibition of 
7, 12-dimethylbenz-[a]anthracene-induce preneoplastic 
lesions in mouse mammary organ culture model. These 
observations suggested that cryptolepinone was a 
potential chemopreventive agent.  
The polyphenol extract of the plant was tested together 
with polyphenol extract of other medicinal plants for 
antioxidant activity through free radical scavenging. The 
tests were performed using the phosphomolybdenum 
reduction (Prieto et al., 1998) and the ABTS radical 
cation decolorization assays (Re et al., 1999) with trolox 
as standard antioxidant. The results showed that there 
was a good correlation between the two methods (r = 0.9) 
and S. acuta had a weak free radical scavenging 
according to values recorded with bark extracts of K. 
Senegalensis, P. erinaceus and C. micranthum in the 
same study. The activities were highly correlated with the 
total phenolic content determined by the Folin-Ciocalteu 
reagent (Singleton et al., 1999) with gallic acid as 
standard (r = 0.94 and r = 0.91 with the two assays 
respectively). 
In another study, Otero et al. (2000a, b) showed that 
the ethanolic extract of the plant had a moderate activity 
against the lethal effect of Bothrops atrox venom. In 
Western Kenya where the plant is consumed as legume, 
a study using Brine shrimp lethality tests revealed that 
the plant was toxic (LC50 = 99.4 g/ml). The author 
concluded that the plant can cause acute or chronic 
toxicities when consumed in large quantities or over a 
long period of time (Orech et al., 2005). 
Malairajan et al. (2006) had demonstrated the 
analgesic properties of the whole plant extract in animal 
model. The authors conducted the tests using two 
methods the hot plate method described by Woolfe and 
Mac Donalds (1944) and the tail immersion method 
described by Dykstra and Woods (1986). The screening 
did not result in the isolation of single compounds but the 
authors suggested that the observed analgesic activity 
may be due to steroidal compounds the plant contains 
(Figure 1). 
 























PHARMACOLOGICAL PROPERTIES OF TWO SINGLE 
COMPOUNDS ISOLATED FROM S. ACUTA: 




Cryptolepine (5-methyl indolo [2,3b]-quinoline) is a 
natural alkaloid occurring in S. acuta, that was first 
isolated from the roots of Cryptolepis triangularis. This 
compound is the main alkaloid present in the roots of 
Cryptolepis sanguinolenta, a plant traditionally used in 
Central and West Africa for the treatment of rheumatism, 
urinary and respiratory infections. Cryptolepine presents 
a large spectrum of biological properties, including 
hypotensive and antipyretic, antimuscarinic, antibacterial 
and anti-inflammatory effects (Bonjean et al., 1998). It 
also possesses potent in vitro activity against P. 
falciparum, the main parasite species responsible for 
malaria. The mechanism of action of this antimalarial 
product remains unclear; at least two independent effects 
may together lead to a potent activity. First, it behaves 
like a DNA intercalator (Bonjean et al., 1998). Second, it 
may act like chloroquine by inhibiting the detoxification of 
heame in red blood cells (Wright et al., 2001). This is 
supported by a fluorescent microscopy study, which 
suggested that cryptolepine accumulates into parasite 
structures that may correspond to the parasite nucleus 
(Arzel et al., 2001). However, cryptolepine failed to cure 
malaria in mice by oral route, by intra peritoneal injection 
the compound showed toxic effects. These observations 
led to the investigation of its synthetic analogues such as 
2,7-dibromocryptolepine (Wright, 2005). 
It has been proposed that crytolepine exerts its 
cytotoxic action via the inhibition of DNA synthesis and 
stabilization of topoisomerase II-DNA covalent 
complexes. In a study conducted to elucidate the strength 
and mode of binding to DNA of cryptolepine and two 
other alkaloids by spectroscopy, Dassonneville et al. 
(1999) found that the alkaloid binds tightly to DNA and 
behaves as typical intercalating agent, thus it stabilizes 
the topoisomerase II-DNA covalent complex and 
stimulates the cutting of DNA by topoisomerase II, but the 
drug does not exhibit a preference for cutting at a specific 
base. However, the flow cytometry analysis showed that 
the drug alters the cell cycle distribution, but no sign of 
drug-induced apoptosis was detected when evaluating 
the internucleosomal fragmentation of DNA in cells. The 
authors suggested that cryptolepine-treated cells 
probably die via necrosis rather than via apoptosis and 
there was evidence that DNA and topoisomerase II are 
the primary targets of cryptolepine. In another study, the 
same authors found later that Cryptolepine induce 
apoptosis in HL60 leukaemia cells (Dassonneville et al., 
2000). Recently, the structure of a cryptolepine-DNA 
complex was elucidated by X-ray crystallography. 
Lisgarten et al. (2002) demonstrated that the drug 
interacts with the CC sites of the d(CCTAGG)2 
oligonucleotide. 






Scopoletin (6-methoxy-7-hydroxycoumarin) is a coumarin 
that has been isolated from many plants species. The 
compound has been tested for many pharmacological 
properties, we list below few examples of the described 
properties of the compound. Yang et al. (2007) observed 
that the compound significantly increased lipoprotein 
lipase activity 3T3-L1 adipocytes in dose- and time- 
dependent manners. Scopoletin did not release the 
enzyme from the adipocyte membrane and, instead, 
decreased the enzyme mRNA level, suggesting a post 
transcriptional control. In the same study the compound 
was also found to partially reverse tumor necrosis factor-
alpha-induced suppression of lipoprotein lipase activity, 
thus the compound may act as a facilitator of plasma 
triglyceride clearance. Looking for the possible mode of 
action of scopoletin in the inflammatory cytokine 
production using CCRF-CEM leukemia cells, Moon et al. 
(2007) found that scopoletin was a potential regulatory of 
inflammatory reactions mediated by mast cells. 
Scopoletin was also found to inhibit leukemia cell 
proliferation. Tested against multidrug resistant subline 
CEM/ADR5000 cells together with standard cytostatic 
drugs, doxorubicin, vincristin and paclitaxel the cells did 
not exhibit cross resistance to the compound in contrast 
with what was observed with the standard drugs (Adams 
et al., 2006). However the compound was also found to 
exert a cytotoxic effect on tumoral lymphocytes (Manuele 
et al., 2006). Finally, scopoletin was found to inhibit the 
thyroid function and hyperglycemia without hepatotoxicity 






S. acuta is a plant of wide usage in traditional medicine. 
Following these traditional usages many studies have 
been conducted in laboratories for the efficiency of the 
plant. It is now evident that the plant has a good 
antiplasmodial activity due to its alkaloids principally 
cryptolepine the main alkaloid of the plant. It is also 
demonstrated that the plant is active on several bacterial 
strains. Many other compounds which are demonstrated 
to have interesting pharmacological properties alone 
have been isolated from the plant, in addition the plant 
may have many other properties since it has not been 
tested for all desired pharmacological activities. However 
it should be noted that all laboratory screenings have 
been carried out with laboratory classical extractions as it 
is often observed with other medicinal plants. No study 
has been conducted with traditional preparation; this 
must be the priority for two reasons. First people still use 
the plant even if laboratory screenings do not confirm the 
assumed activity, so the laboratory results in the 
conditions of the traditional usage is more pertinent and 
can directly improve this usage. Secondly most of  theses  
 




extracts act sometimes by synergistic effects so the 
fractionation may result in the lost of the activity, in 
addition the establishment of the drug from pure single 
compound may be too expensive so the drug may not be 
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